HokMind, a Beijing startup from March 2026, sells a bionic face with 32 degrees of freedom. This report sizes the market and separates three layers of evidence.
On September 20, a Chinese company put two personal robots on sale in China, starting at RMB 19,999 (about $2,800). Anyone typing "a robot that does my chores" into a search box now has, for the first time, an option they can actually order. It does not do chores. The one that does sits on the other side of the Pacific, costs roughly seven times as much, and still keeps a remote operator on call for the hard tasks. Article structure: - 1. What People Search For, and What Is Actually on Sale - 2. What $2,800 Buys - 3. The Price Tag on Chores - 4. Why Companionship Comes First - 5. What to Watch Over the Next Twelve Months
On July 8, 2026, engineers and surgeons at the University of California San Diego published a paper in Nature reporting that two teleoperated humanoid robots had performed laparoscopic gallbladder removals on live pigs. The platform was an off-the-shelf Unitree G1, nicknamed Surgie, standing five feet tall and weighing 60 pounds. The dedicated surgical system it was measured against weighs about 1,800 pounds. The paper also supplies the numbers that matter: straight-line tracking error of about 1.3 millimeters, circular tracking error of about 10.4 millimeters, and 156 milliseconds of latency. Across two dry-lab tasks the humanoid already beat unassisted human hands, while remaining clearly behind the da Vinci Xi. This article unpacks that scorecard, and the four gates still standing between the robot and a clinical operating room. **Article structure** : - 1. The Surgical Record: Two Live Porcine Cholecystectomies - 2. Why a General-Purpose Humanoid: Footprint, Reach and Cost - 3. Measuring Precision: Straight Lines, Curves and 156 Milliseconds - 4. Four Gates Before Clinical Use: Sterility, Ports, Recalibration and Remote Operation - 5. Conclusion: What the First Time Proves, and What It Does Not